文献速递炎症性肠病胃肠动力与功能性疾病

综述:肠道5-羟色胺(5-HT)信号在炎症性肠病中的多种潜在作用

Review article: the many potential roles of intestinal serotonin (5-hydroxytryptamine, 5-HT) signalling in inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2017-07-24

该综述回顾1952至2017年文献,探讨肠道5-羟色胺(5-HT)信号系统在肠道功能尤其炎症性肠病(IBD)中的作用。炎症似乎影响5-HT合成、释放、受体表达和再摄取等主要环节;多数动物模型研究显示调节选择性5-HT受体或5-HT信号终止可改变肠道炎症可能性及严重度,但靶向性人体研究较少。

要点

  • 炎症似乎影响肠道5-HT信号的合成、释放、受体表达和再摄取能力等主要环节。
  • 多数动物模型研究显示,激动5-HT4受体、拮抗5-HT3受体或使用5-HT再摄取抑制剂可改变肠道炎症可能性及严重度。
  • 靶向性研究这些关系的人体研究较少;作者认为需进一步人体研究以更全面理解5-HT在此背景下的病理生理机制。

核心结论

  • 本综述讨论的见解有较强潜力带来新的诊断和治疗工具,以改善IBD及其他相关疾病的管理。
  • 作者认为,聚焦于调节肠道中选择性5-HT受体和再摄取转运体活性的策略,可能对控制疾病活动度和/或相关症状有效。
  • 作者指出,仍需进一步人体研究以更全面理解5-HT在此背景下的病理生理机制。

研究设计与样本

  • 综述类文章;检索并回顾1952年至2017年间研究和讨论5-HT信号在胃肠功能与IBD中作用、以及炎症对肠道5-HT信号元素影响的稿件。

主要发现

  • 炎症似乎影响肠道5-HT信号的每一个主要元素,包括5-HT合成、释放、受体表达和再摄取能力。
  • 许多研究(多数利用动物模型)表明,通过激动5-HT4受体和拮抗5-HT3受体调节选择性5-HT受体,或通过5-HT再摄取抑制剂调节5-HT信号终止,可改变肠道炎症的可能性和/或严重度及其并发症状。
  • 针对这些关系进行靶向研究的人体研究较少。

局限性

  • 许多研究利用动物模型。
  • 针对这些关系进行靶向研究的人体研究较少。
  • 作者指出仍需进一步人体研究以更全面理解5-HT在此背景下的病理生理机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Serotonin (5-hydroxytryptamine, 5-HT) is an important mediator of every major gut-related function. Recent investigations also suggest that 5-HT can influence the development and severity of inflammation within the gut, particularly in the setting of inflammatory bowel disease (IBD). AIM: To review the roles that the intestinal serotonin signalling system plays in gut function, with a specific focus on IBD. METHODS: We reviewed manuscripts from 1952 to 2017 that investigated and discussed roles for 5-HT signalling in gastrointestinal function and IBD, as well as the influence of inflammation on 5-HT signalling elements within the gut. RESULTS: Inflammation appears to affect every major element of intestinal 5-HT signalling, including 5-HT synthesis, release, receptor expression and reuptake capacity. Importantly, many studies (most utilising animal models) also demonstrate that modulation of selective serotonergic receptors (via agonism of 5-HT4 R and antagonism of 5-HT3 R) or 5-HT signal termination (via serotonin reuptake inhibitors) can alter the likelihood and severity of intestinal inflammation and/or its complicating symptoms. However, there are few human studies that have studied these relationships in a targeted manner. CONCLUSIONS: Insights discussed in this review have strong potential to lead to new diagnostic and therapeutic tools to improve the management of IBD and other related disorders. Specifically, strategies that focus on modifying the activity of selective serotonin receptors and reuptake transporters in the gut could be effective for controlling disease activity and/or its associated symptoms. Further studies in humans are required, however, to more completely understand the pathophysiological mechanisms underlying the roles of 5-HT in this setting.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Coates MD, Tekin I, Vrana KE, et al. Review article: the many potential roles of intestinal serotonin (5-hydroxytryptamine, 5-HT) signalling in inflammatory bowel disease. Aliment Pharmacol Ther. 2017. PMID: 28737264. doi:10.1111/apt.14226

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。